1. The interplay of co-infections in shaping COVID-19 severity: Expanding the scope beyond SARS-CoV-2
- Author
-
Budhadev Baral, Vaishali Saini, Meenakshi Kandpal, Pratik Kundu, Amit Kumar Dixit, Hamendra Singh Parmar, Ajay Kumar Meena, Pankaj Trivedi, and Hem Chandra Jha
- Subjects
Co-infection ,COVID-19 ,Pandemic ,Cytokine storm ,Infectious and parasitic diseases ,RC109-216 ,Public aspects of medicine ,RA1-1270 - Abstract
High mortality has been reported in severe cases of COVID-19. Emerging reports suggested that the severity is not only due to SARS-CoV-2 infection, but also due to coinfections by other pathogens exhibiting symptoms like COVID-19. During the COVID-19 pandemic, simultaneous respiratory coinfections with various viral (Retroviridae, Flaviviridae, Orthomyxoviridae, and Picoviridae) and bacterial (Mycobacteriaceae, Mycoplasmataceae, Enterobacteriaceae and Helicobacteraceae) families have been observed. These pathogens intensify disease severity by potentially augmenting SARSCoV-2 replication, inflammation, and modulation of signaling pathways. Coinfection emerges as a critical determinant of COVID-19 severity, principally instigated by heightened pro-inflammatory cytokine levels, as cytokine storm. Thereby, in co-infection scenario, the severity is also driven by the modulation of inflammatory signaling pathways by both pathogens possibly associated with interleukin, interferon, and cell death exacerbating the severity. In the current review, we attempt to understand the role of co- infections by other pathogens and their involvement in the severity of COVID-19.
- Published
- 2024
- Full Text
- View/download PDF